Hydrocodone reclassification harms millions suffering from chronic pain

7/29/2016

Matt Jeffers The Hill (Blog) Nearly two years ago, the DEA made the lives of millions of Americans more difficult. On August 22, 2014, the agency moved hydrocodone combination drugs such as Vicodin from Schedule III to Schedule II. This reclassification created tougher rules, greater burea...

New data analysis points to illegally obtained opioids as 'driving force' behind epidemic

7/27/2016

Colin A. Young State House News Service via The Salem News BOSTON — Authorized by a law signed last year to collect information from health care agencies, law enforcement departments, the court system and other state agencies, the Department of Public Health is working to demystif...

The nation’s opioid crisis garners attention at party conventions

7/26/2016

Katie Zezima The Washington Post The nation’s epidemic of opioid abuse, which has killed thousands of people over the past decade through powerful prescription painkillers and heroin, has taken on a prominent role at the Democratic National Convention — a sign of the issue&rsqu...

Durbin Sends Letter to DEA Calling for Stricter Limits of Opioid Pills

7/24/2016

PoliticalNews.me CHICAGO – U.S. Senator Dick Durbin (D-IL) released a letter to the Drug Enforcement Administration (DEA), calling on the agency to use its power to ‎more aggressively combat the opioid epidemic that is affecting communities across Illinois and the country. With its...

Governors Sign Compact To Fight Opioid Addiction

7/15/2016

AlexandriaNews.org Forty-six governors signed the Compact to Fight Opioid Addiction, developed by and released through the National Governors Association on July 13. By signing the compact, governors are agreeing to redouble their efforts to fight the opioid epidemic with new steps to r...

What we actually know about opioid abuse might not be what you think

7/15/2016

Susan Sered The Hill President Obama's bill to expand access to treatment for prescription drug abuse and heroin use passed in the House last week and the Senate this week. (The president has said he'll sign the bill, even though it doesn't include the $1.1 billion he asked for.) But as comb...

DURECT's Abuse-Deterrent Opioid Poised for FDA Approval

7/14/2016

Marketwired SAN FRANCISCO, CA--(Marketwired - July 14, 2016) - Oxycodone is a powerful and lucrative painkiller, but one with serious downsides. Dependency on the opioid has become a major issue medically, politically and, most profoundly¬¬, for the patients whose addictions have become...

White House to Announce New Opioid Regulations

7/6/2016

The White House on Wednesday will announce a set of administrative regulations aimed at addressing the opioid crisis, as a funding fight in Congress threatens to derail bipartisan bills from both chambers. The administration’s actions come as a congressional conference committee on bills ...

Government expands access to drug used to treat opioid abuse

7/6/2016

The federal government Wednesday nearly tripled, to 275, the number of patients to which an authorized doctor can prescribe a drug that helps patients control their dependence on painkillers and heroin. The move was part of several announced by the Obama administration as part of an effort to s...

Intellipharmaceutics Reports Update on Rexista™ XR: FDA Grants Waiver of NDA Filing Fee, and Topline Pharmacokinetics Results Indicate No Food Effect

7/6/2016

TORONTO, July 05, 2016 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (IPCI) (TSX:I) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targete...